These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8695079)

  • 1. Cumulative reduction in serum cholinesterase following repeated therapeutic plasma exchange.
    Collard CD; Baker BW; Johnson D; Bressler R; Harati Y
    J Clin Anesth; 1996 Feb; 8(1):44-8. PubMed ID: 8695079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Plasma cholinesterase variations as a result of prolonged neuromuscular blockade. Review and problems encountered in two cases of prolonged neuromuscular blockade after muscle relaxation with succinylcholine as compared to mivacurium].
    Lang C; Lukasewitz P; Wulf H; Geldner G
    Anaesthesist; 2002 Feb; 51(2):134-41. PubMed ID: 11963306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mivacurium compared with succinylcholine in children with liver disease.
    Green DW; Fisher M; Sockalingham I
    Br J Anaesth; 1998 Sep; 81(3):463-5. PubMed ID: 9861140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of succinylcholine on subsequently administered mivacurium in children.
    Jalkanen L; Meretoja OA; Taivainen T
    Acta Anaesthesiol Scand; 1995 Nov; 39(8):1024-7. PubMed ID: 8607302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuromuscular effects of mivacurium in 2- to 12-yr-old children with burn injury.
    Martyn JA; Goudsouzian NG; Chang Y; Szyfelbein SK; Schwartz AE; Patel SS
    Anesthesiology; 2000 Jan; 92(1):31-7. PubMed ID: 10638896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The neuromuscular effects of mivacurium chloride during propofol anesthesia in children.
    Shorten GD; Crawford MW; St Louis P
    Anesth Analg; 1996 Jun; 82(6):1170-5. PubMed ID: 8638786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged neuromuscular block due to cholinesterase depletion by plasmapheresis.
    Naik B; Hirshhorn S; Dharnidharka VR
    J Clin Anesth; 2002 Aug; 14(5):381-4. PubMed ID: 12208445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical importance of plasma cholinesterase for the anaesthetist.
    Pedersen NA; Jensen FS
    Ann Acad Med Singap; 1994 Nov; 23(6 Suppl):120-4. PubMed ID: 7710221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of the enzymic degradation of suxamethonium and mivacurium increases the onset time of submaximal neuromuscular block.
    Beaufort TM; Nigrovic V; Proost JH; Houwertjes MC; Wierda JM
    Anesthesiology; 1998 Sep; 89(3):707-14. PubMed ID: 9743409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neuromuscular recovery following mivacurium is predictable in patients with severe systemic disease prognoses].
    Blobner M; Busley R; Mann R; Jelen-Esselborn S; Kochs E
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1999 Oct; 34(10):638-41. PubMed ID: 10548961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pseudocholinesterase-mediated hydrolysis is superior to neostigmine for reversal of mivacurium-induced paralysis in vitro.
    Yang HS; Goudsouzian N; Martyn JA
    Anesthesiology; 1996 Apr; 84(4):936-44. PubMed ID: 8638849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mivacurium. A review of its pharmacology and therapeutic potential in general anaesthesia.
    Frampton JE; McTavish D
    Drugs; 1993 Jun; 45(6):1066-1089. PubMed ID: 7691494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction between mivacurium and succinylcholine.
    Erkola O; Rautoma P; Meretoja OA
    Anesth Analg; 1995 Mar; 80(3):534-7. PubMed ID: 7864420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of succinylcholine on the recovery of block produced by mivacurium in rats.
    Kanyamibwa D; Tsaousi G; Karakoulas K; Thomareis O; Parlapani A; Makedou AH; Giala M
    Methods Find Exp Clin Pharmacol; 2008 Apr; 30(3):187-91. PubMed ID: 18597002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suxamethonium and mivacurium sensitivity from pregnancy-induced plasma cholinesterase deficiency.
    Davies P; Landy M
    Anaesthesia; 1998 Nov; 53(11):1109-11. PubMed ID: 10023281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of drug-induced low plasma cholinesterase activity on the pharmacokinetics and pharmacodynamics of mivacurium.
    Ostergaard D; Rasmussen SN; Viby-Mogensen J; Pedersen NA; Boysen R
    Anesthesiology; 2000 Jun; 92(6):1581-7. PubMed ID: 10839906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The clinical pharmacology of mivacurium].
    Diefenbach C; Mellinghoff H
    Anaesthesist; 1997 May; 46(5):385-8. PubMed ID: 9245207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzymatic antagonism of mivacurium-induced neuromuscular blockade by human plasma cholinesterase.
    Naguib M; Daoud W; el-Gammal M; Ammar A; Turkistani A; Selim M; Altamimi W; Sohaibani MO
    Anesthesiology; 1995 Oct; 83(4):694-701. PubMed ID: 7574048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of plasma cholinesterase activity on mivacurium infusion rates.
    Hart PS; McCarthy GJ; Brown R; Lau M; Fisher DM
    Anesth Analg; 1995 Apr; 80(4):760-3. PubMed ID: 7893031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-response relationship for mivacurium in patients with phenotypically abnormal plasma cholinesterase activity.
    Ostergaard D; Jensen FS; Skovgaard LT; Viby-Mogensen J
    Acta Anaesthesiol Scand; 1995 Nov; 39(8):1016-8. PubMed ID: 8607300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.